Company Snapshot: Nemaura Medical Inc.

NMRD
Last	Change	Volume	High	Low

Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.

Client News

1. May 2 2019 Nemaura Announces Open-Source Software for its Continuous Glucose Monitor SugarBEAT®
2. Apr 23 2019 Nemaura Announces Successful Completion of Summative Human Factors Usability Study for SugarBEAT®
3. Apr 16 2019 Nemaura Announces Addition of New Predictive Alert Functionality to SugarBEAT®
4. Mar 28 2019 Nemaura CEO Provides Update to Shareholders